Drug Type Small molecule drug |
Synonyms Amlodipine Besilate/Atorvastatin Calcium Hydrate, Amlodipine Besylate/Atorvastatin Calcium Hydrate, Amlodipine/atorvastatin + [6] |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (30 Jan 2004), |
Regulation- |
Molecular FormulaC33H35CaFN2O5 |
InChIKeyBWFCZHDTTAYGNN-CNZCJKERSA-N |
CAS Registry134523-03-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Amlodipine Besylate/Atorvastatin Calcium | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperlipoproteinemia Type II | JP | 07 Jul 2009 | |
Angina Pectoris | CN | 03 Apr 2008 | |
Coronary Disease | CN | 03 Apr 2008 | |
Hypercholesterolemia | CN | 19 Apr 2005 | |
Angina Pectoris, Variant | US | 30 Jan 2004 | |
Angina, Stable | US | 30 Jan 2004 | |
Heterozygous familial hypercholesterolemia | US | 30 Jan 2004 | |
Homozygous familial hypercholesterolemia | US | 30 Jan 2004 | |
Hyperlipoproteinemia Type III | US | 30 Jan 2004 | |
Hypertension | US | 30 Jan 2004 | |
Hypertriglyceridemia | US | 30 Jan 2004 | |
Primary hypercholesterolemia | US | 30 Jan 2004 |
Phase 4 | 159 | kudsoofloc(tbltwsxzxc) = fjjbnjqxnt bbhvyazzfv (hxznynehss, xhuecnffsz - pnqitkmery) View more | - | 03 Dec 2012 | |||
Phase 4 | 1,531 | cogdkqcbwp(oofqjbyutc) = vodnqgmyci eugebrxrbv (mqkfbucowi, dsnzvnasej - igzjkwsimb) View more | - | 11 Nov 2011 | |||
Phase 4 | 245 | placebo+Caduet (Norvasc + TLC) | poyjyyggqd(gowhalgdnr) = chzjrpshml wyddfsbuxm (ywoxlgjjmx, gbkjpbumad - gawnfghqhf) View more | - | 06 Nov 2009 | ||
Norvasc placebo+atorvastatin calcium+TLC+amlodipine besylate (Caduet + TLC) | poyjyyggqd(gowhalgdnr) = jpksazxong wyddfsbuxm (ywoxlgjjmx, hazanlkaai - nthrowudui) View more | ||||||
Not Applicable | 2,245 | skwmwaphvv(yjsouunqtn) = oowiaiqctc esbkzlfnww (cnwdjihzrn ) | - | 01 Aug 2009 | |||
Phase 3 | 165 | (CI-1038 2.5 mg/5 mg) | ogidcqsqat(keayjjdrtj) = iihazjibyw wakaamcijz (gchyvqcnvw, veqrbdpyqy - scpnuccuvd) View more | - | 13 Apr 2009 | ||
(CI-1038 2.5 mg/10 mg) | ogidcqsqat(keayjjdrtj) = xnzxtnnnxb wakaamcijz (gchyvqcnvw, qrbqbmhtzb - bnxncgqynt) View more |